Palvella Therapeutics, Inc. (PVLA)

Palvella Therapeutics Statistics

Total Valuation

PVLA has a market cap or net worth of $1.81 billion. The enterprise value is $1.77 billion.

Market Cap	1.81B
Enterprise Value	1.77B

Important Dates

The next estimated earnings date is Monday, March 30, 2026, before market open.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

PVLA has 13.44 million shares outstanding. The number of shares has increased by 60.51% in one year.

Current Share Class	13.44M
Shares Outstanding	13.44M
Shares Change (YoY)	+60.51%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	14.76%
Owned by Institutions (%)	60.64%
Float	6.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	38.70
P/TBV Ratio	46.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.41.

Current Ratio	6.49
Quick Ratio	6.38
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.88

Financial Efficiency

Return on equity (ROE) is -301.19% and return on invested capital (ROIC) is -63.87%.

Return on Equity (ROE)	-301.19%
Return on Assets (ROA)	-47.54%
Return on Invested Capital (ROIC)	-63.87%
Return on Capital Employed (ROCE)	-55.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$2.31M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +618.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+618.19%
50-Day Moving Average	94.39
200-Day Moving Average	63.47
Relative Strength Index (RSI)	70.95
Average Volume (20 Days)	439,984

Short Selling Information

The latest short interest is 1.37 million, so 10.20% of the outstanding shares have been sold short.

Short Interest	1.37M
Short Previous Month	1.35M
Short % of Shares Out	10.20%
Short % of Float	20.15%
Short Ratio (days to cover)	5.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.66M
Pretax Income	-32.95M
Net Income	-32.37M
EBITDA	n/a
EBIT	-31.66M
Earnings Per Share (EPS)	-$3.53

Balance Sheet

The company has $63.57 million in cash and $16.02 million in debt, with a net cash position of $47.55 million or $3.54 per share.

Cash & Cash Equivalents	63.57M
Total Debt	16.02M
Net Cash	47.55M
Net Cash Per Share	$3.54
Equity (Book Value)	38.68M
Book Value Per Share	3.49
Working Capital	56.63M

Cash Flow

Operating Cash Flow	-25.47M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PVLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.51%
Shareholder Yield	-60.51%
Earnings Yield	-1.78%
FCF Yield	n/a

Analyst Forecast

The average price target for PVLA is $154.59, which is 14.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$154.59
Price Target Difference	14.49%
Analyst Consensus	Strong Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3